Genus (LSE:GNS) Institutional Ownership: 52.29% (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:GNS Genus PLC LSE:GNS
66 GF Score
Price £22.82
GF Value £20.54
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Genus Institutional Ownership?

Genus LSE:GNS -0.70% 66 Institutional Ownership is 52.29% as of Aug. 24, 2026. GuruFocus rates LSE:GNS with a GF Score™ of 66/100 and a GF Value™ of £20.54 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genus's institutional ownership is 52.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genus's Insider Ownership is 0.71%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genus's Float Percentage Of Total Shares Outstanding is 0.00%.

Genus Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Genus's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus Institutional Ownership Chart

Genus Historical Data

The historical data trend for Genus can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 49.78 50.61 52.72 53.44 54.74 54.79 51.92 52.35 52.22 52.29
LSE:GNS
66GF Score
Genus PLC LSE:GNS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genus Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 52.29% mean?
Genus (LSE:GNS) has a Institutional Ownership of 52.29% as of Aug. 24, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Genus and its competitors.
Is Genus' Institutional Ownership too high?
Genus' current Institutional Ownership is 52.29%. Overall, Genus has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Genus' Institutional Ownership compare to VRTX and REGN?
Genus' Institutional Ownership of 52.29% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Genus and its competitors. Genus's current Institutional Ownership is 52.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (LSE:GNS) is currently considered Modestly Overvalued. The stock's GF Value™ is £20.54, compared to a current price of £22.82 — trading 11.1% above its estimated fair value. The current Institutional Ownership is 52.29%. Genus' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Genus (LSE:GNS), the current Institutional Ownership is 52.29% as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (LSE:GNS) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £22.82 is trading 11.1% above its estimated GF Value™ of £20.54. GuruFocus considers Genus to be Modestly Overvalued.

Key valuation signals for LSE:GNS:

  • Institutional Ownership: 52.29%
  • GF Value™: £20.54 vs. price of £22.82 (11.1% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the LSE:GNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
66GF Score

Get the complete analysis for LSE:GNS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£22.82
Price
£20.54
GF Value